Summary
Machine-generated summaryThis tender covers the award of rebate agreements for pharmaceuticals under Section 130a(8) of the German Social Security Code V (SGB V), i.e. generic drug discount contracts for statutory health insurance. The buyer is a German sickness fund operating in Germany. The notice lists around 45 active ingredients or ingredient combinations, including Mebeverine, Palonosetron, Lactulose, Rivaroxaban, Ezetimibe, Sildenafil and Nintedanib, each with one to three contract awards. Rebate agreements are concluded via an open tender procedure. No estimated value, award deadline, or further eligibility details are stated in the notice, so interested suppliers of generic medicines should consult the full tender documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile2 open tenders right now
- Legal advice and representation - Framework contract for pitch consultancy No deadline published
- Business and management consultancy - Framework agreement for pitch consultancy No deadline published
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Submission deadline: Moved 1 day EARLIER: now September 21, 2026, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,804,288
- Buyer track record on Aperlena
- 23 notices tracked · 1 awarded
Never miss a tender like this
92 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert